论文信息 - Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions. - 字舞流文

Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions.

N. Normanno | G. de Feo | J. Bryce | M. Di Maio | M. Piccirillo | A. Morabito | F. Perrone | Fabiano Falasconi | A. Del Giudice | E. De Maio | G. De Feo